25 May 2013
Keywords: qlt, starts, 2nd, gen, cancer, drug, trials
Article | 11 May 1992
As Canada's Quadra Logic Technologies heads towards marketing its first
anticancer compound, the Canadian government has given the go-ahead for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com